Lysosomal membrane damage in soluble Aβ-mediated cell death in Alzheimer's disease

Neurobiology of Disease

Volumn 8, Issue 1, 2001, Pages 19-31

  Ditaranto, Kristen ^a   Tekirian, Tina L ^b   Yang, Austin J ^a  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; FREE RADICAL; HYDROLASE; PROTEINASE;

ALZHEIMER DISEASE; ARTICLE; CYTOPLASM; ENDOSOME; ENZYME DEGRADATION; ENZYME RELEASE; FLUORESCENCE; LYSOSOME MEMBRANE; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; NERVE CELL NECROSIS; OXIDATION; PRIORITY JOURNAL;

EID: 0035110055     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2000.0364     Document Type: Article

References (42)

1. Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, A beta 1-42, in differentiated PC12 cells
2. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs
3. beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: Implications to alzheimer's disease
4. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system
5. Properties of the endosomal-lysosomal system in the human central nervous system: Disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease
6. Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease
7. Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain
8. Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease
9. An antiserum against amyloid beta-protein precursor detects a unique peptide in Alzheimer brain
10. Evidence for lysosomal processing of amyloid beta-protein precursor in cultured cells
11. Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor
12. Normal processing of the Alzheinler's disease amyloid beta protein precursor generates potentially amyloidogenic carboxyl-terminal derivatives
13. Soluble amyloid Abeta-(1-40) exists as a stable dimer at low concentrations
14. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans
15. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives
16. Regulation of a novel pathway for cell death by lysosomal aspartic and cysteine proteinases
17. Multiple pathways of apoptosis in PC12 cells: CrmA inhibits apoptosis induced by beta-amyloid
18. Inhibitors of V-type ATPases, bafilomycin A1 and concanamycin A, protect against beta-amyloid-mediated effects on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction
19. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein
20. Induction of cell death by the lysosomotropic detergent MSDH
21. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease
22. Amyloid beta-peptide impairs ion-motive ATPase activities: Evidence for a role in loss of neuronal Ca2+ homeostasis and cell death
23. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide
24. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex
25. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease
26. Role of an acidic compartment in tumor-necrosis-factoralpha-induced production of ceramide, activation of caspase-3 and apoptosis
27. The lysosomal system in neurons: Involvement at multiple stages of Alzheimer's disease pathogenesis
28. Cellular injury induced by oxidative stress is mediated through lysosomal damage
29. Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease
30. Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state
31. Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro
32. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity
33. The role of iron in beta amyloid toxicity
34. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease
35. Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease
36. Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease
37. Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles
38. The neuropathology of Alzheimer's disease: Neuroimaging
39. Intracellular A beta 1-42 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells
40. Acridine orange-mediated photodamage to cultured cells
41. Photooxidative damage to lysosomes of cultured macrophages by acridine orange
42. Activation of pro-caspase-7 by serine proteases includes a non-canonical specificity